(Q36993370)

17 August 2017

1 reference

title

Adjuvant therapy in pancreatic cancer: a critical appraisal (English)

1 reference

17 August 2017

1 reference

Helmut Oettle

1

1 reference

PubMed ID

17983252

17 August 2017

Peter Neuhaus

series ordinal

2

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

67

1 reference

17 August 2017

16

1 reference

17 August 2017

2293-2310

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767160-00001

17 August 2017

0 references

cites work

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767160-00001

A challenge to the therapeutic nihilism of ESPAC-1.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767160-00001

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

21 January 2018

1 reference

12 December 2020

Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings

1 reference

12 December 2020

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

12 December 2020

Results of pancreatectomy with radiation therapy for pancreatic cancer.

1 reference

12 December 2020

Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil

1 reference

12 December 2020

The role of intraoperative therapy by electron beam and combination of adjuvant chemotherapy and external radiotherapy in carcinoma of the pancreas.

1 reference

12 December 2020

The role of gemcitabine alone and in combination in the treatment of pancreatic cancer

1 reference

12 December 2020

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

1 reference

12 December 2020

Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas.

1 reference

12 December 2020

Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer

1 reference

12 December 2020

Intraoperative radiotherapy for pancreatic adenocarcinoma.

1 reference

12 December 2020

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

12 December 2020

Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer

1 reference

12 December 2020

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

12 December 2020

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

1 reference

12 December 2020

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

12 December 2020

Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma

1 reference

12 December 2020

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

12 December 2020

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.

1 reference

12 December 2020

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

12 December 2020

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

1 reference

12 December 2020

Experimental and clinical studies with intraoperative radiotherapy

1 reference

12 December 2020

Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study

1 reference

12 December 2020

A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer

1 reference

12 December 2020

Adjuvant therapy of resected adenocarcinoma of the pancreas

1 reference

12 December 2020

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer

1 reference

12 December 2020

Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

The Virginia Mason approach to localized pancreatic cancer

1 reference

12 December 2020

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

12 December 2020

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer

1 reference

12 December 2020

Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study

1 reference

12 December 2020

Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer

1 reference

12 December 2020

Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study

1 reference

12 December 2020

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

1 reference

12 December 2020

Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis

1 reference

12 December 2020

Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma

1 reference

12 December 2020

Intraoperative and postoperative radiotherapy in pancreatic cancer

1 reference

12 December 2020

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

Chemotherapy for pancreatic cancer.

1 reference

12 December 2020

10.2165/00003495-200767160-00001

Identifiers

DOI

1 reference

PubMed ID

17983252

Dimensions Publication ID

17 August 2017

0 references

1 reference

PubMed ID

17983252